Quick Overview: With the major research breakthroughs over the past 30 years in understanding how to The video was taken of a presentation at the 2014 Society for Join Roger Blumenthal, MD, FASPC, for a practical review of the new 2026 ACC/AHA Multi-Society Dyslipidemia Guideline and its ...

Apsi Prevention Talk 9 Scaling - Detailed Overview & Context

With the major research breakthroughs over the past 30 years in understanding how to The video was taken of a presentation at the 2014 Society for Join Roger Blumenthal, MD, FASPC, for a practical review of the new 2026 ACC/AHA Multi-Society Dyslipidemia Guideline and its ... Recognize where SPD leadership gaps quietly create accreditation exposure under QAPI, infection Kevin Ginsburg, MD, urologic oncologist at the Karmanos Cancer Institute/Wayne State University in Detroit, presents a webinar ... In many TMD cases, identifying overtreatment successes proves elusive, as both patients and treating dentists often perceive ...

The Accelerating Medicines Partnership (AMP) program is a public-private partnership between the National Institutes of Health, ... Speaker: Donna Schempp, LCSW, Consultant, Caregiver Services, Dementia Planning. This is part of the October 2012 Atypical ... ... providing care to help protect you from getting an infection or illness as well as spreading it to others now let's TAKE HOME POINTS: Dr Ballantyne discusses efficacy and safety of an oral PCSK9 inhibitor Lisa Gfrerer, M.D., Ph.D., and Christian Chartier, M.D. candidate, discussed, “ChartSweep: A HIPAA- Compliant Tool to Automate ... Dr David Samra (MD, FACSEP) is a Specialist Sport and Exercise Medicine Physician and Founder of Progressive Sports ...

This APIC Consulting webinar explores how healthcare organizations can build infection This video is the recording of our live Insights session with Support Act, where we explored the essential wellbeing services ... Dr. Slakey discusses his recently published article in JACS, Using Process Flow Disruption Analysis to Guide Quality ... Optimizing RAAS Blockade with ACE Inhibitors Padmashri Dr. C. Venkata S. Ram Director, Apollo Institute for Blood Pressure ...

Photo Gallery

APSI Prevention Talk # 9 -  Scaling Out Evidence-Based Prevention Programs
Conference Presentation on Scaling up Effective Prevention Programs
CardioCore Lecture New Lipid Guidelines
Beyond Policy How Leadership Gaps in Sterile Processing Become Accreditation and IP Risks By - ASSI
Is favorable intermediate-risk PCa the future of AS?
When Patients Understand Their Disease, Prevention Changes: AI’s Role in Diagnosis and Communication
Overtreatment ‘Successes’ What Are the Negative Consequences for Patients, Dentists, & Profession?
The Accelerating Medicines Partnership® (AMP®) program in schizophrenia (AMP SCZ): Overview & Vision
9 Resilience and Coping Strategies | Atypical Parkinsonism (DLB, PSP, MSA, CBS/CBD) Symposium
IPAC Basics - What is a Point of Care Risk Assessment (PCRA)?
TAKE HOME POINTS: Dr Ballantyne discusses efficacy and safety of an oral PCSK9 inhibitor
PRS Global Open Tech Talk: ChartSweep: A HIPAA- Compliant Tool to Automate Chart Review
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored